CXCR3 and COVID-19: In line with these results, transcripts for CXCR3, CXCR6, and CCR5 were highly enriched in NK cells as well as CD4+ and CD8+ T cells in COVID-19 patients with moderate disease, suggesting a highly specific accumulation of cells expressing the respective receptors in the lung (Figure 4B).